ResMed Denmark A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.9% 0.5% 0.5% 0.6% 0.6%  
Credit score (0-100)  90 98 99 97 98  
Credit rating  A AA AAA AA AA  
Credit limit (kDKK)  1,305.1 2,310.1 3,162.4 3,191.2 4,106.2  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  0 0 0 0 0  
Gross profit  12,524 13,914 15,492 18,230 21,978  
EBITDA  1,690 3,460 4,481 4,999 7,402  
EBIT  1,483 3,396 4,441 4,977 7,393  
Pre-tax profit (PTP)  1,443.0 3,358.4 4,373.1 4,893.0 7,460.6  
Net earnings  1,124.3 2,617.1 3,404.4 3,812.6 5,817.7  
Pre-tax profit without non-rec. items  1,443 3,358 4,373 4,893 7,461  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Tangible assets total  121 73.9 34.2 12.5 75.5  
Shareholders equity total  12,827 15,444 18,849 22,661 28,479  
Interest-bearing liabilities  0.0 4,509 10,428 11,928 6,532  
Balance sheet total (assets)  23,396 24,548 36,085 41,018 45,276  

Net Debt  -4,382 -3,226 -5,583 3,237 -5,366  
 
See the entire balance sheet

Volume 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  12,524 13,914 15,492 18,230 21,978  
Gross profit growth  -24.1% 11.1% 11.3% 17.7% 20.6%  
Employees  16 16 16 18 19  
Employee growth %  -11.1% 0.0% 0.0% 12.5% 5.6%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  23,396 24,548 36,085 41,018 45,276  
Balance sheet change%  18.2% 4.9% 47.0% 13.7% 10.4%  
Added value  1,689.5 3,459.5 4,480.8 5,017.1 7,402.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -352 -110 -79 -43 54  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 5.0 5.0 5.0  

Profitability 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  11.8% 24.4% 28.7% 27.3% 33.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  6.9% 14.2% 14.6% 12.9% 17.3%  
ROI %  11.5% 19.2% 16.7% 14.9% 20.5%  
ROE %  9.2% 18.5% 19.9% 18.4% 22.8%  

Solidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Equity ratio %  54.8% 62.9% 52.2% 55.2% 62.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -259.3% -93.3% -124.6% 64.8% -72.5%  
Gearing %  0.0% 29.2% 55.3% 52.6% 22.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 1.7% 0.9% 0.8% 0.2%  

Liquidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Quick Ratio  2.0 2.7 1.9 2.0 2.7  
Current Ratio  2.3 3.2 2.3 2.4 3.4  
Cash and cash equivalent  4,381.5 7,735.0 16,010.2 8,690.5 11,898.3  

Capital use efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  12,636.5 16,068.8 19,637.4 23,529.4 30,634.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales / employee  0 0 0 0 0  
Added value / employee  106 216 280 279 390  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  106 216 280 278 390  
EBIT / employee  93 212 278 277 389  
Net earnings / employee  70 164 213 212 306